UnitedHealth’s Democrat investment, and surprise billing bloat debate
The surge in donations comes at a critical juncture for the diversified healthcare giant. As...
The surge in donations comes at a critical juncture for the diversified healthcare giant. As...
According to the inspection report, federal investigators discovered residue and stains "plastered" across production walls...
In a pair of late-stage trials, a drug from AstraZeneca reduced the dangerous flare-ups that...
Novo Nordisk confirmed late Friday that it had informed trial investigators of its decision to...
The unfolding controversy surrounding the American Diabetes Association (ADA) and its handling of member expulsions...
The program represents a significant shift in the federal government’s philosophy toward digital health. Historically,...
The biotechnology sector experienced a day of stark contrasts as two major clinical updates reshaped...
The regulatory landscape, traditionally characterized by its deliberate and cautious pace, is facing an unprecedented...
The landscape of American public health is undergoing a series of tectonic shifts, ranging from...
In a series of recent public reflections and high-stakes congressional testimonies, Dr. Anthony Fauci, the...